Supply Chain Ecosystem Analysis now part of DBMR Reports
India Molecular Diagnostic Controls Market, By Product (Independent Controls, Instrument Specific Controls), Analyte Type (Single Analyte Controls, Multi Analyte Controls), Application (Infectious Disease, Oncology, Genetic Testing, Others), End User (Clinical Laboratories, Hospitals, IVD Manufacturers & Contract Research Organizations, Academic & Research Institutes, Others), Distribution Channel (Retail Sales, Direct Tender) - Industry Trends and Forecast to 2031.
Molecular diagnostic controls are essential for quality assurance in laboratory testing. They serve as standardized samples with known concentrations of specific nucleic acids or other molecular targets. Laboratories use these controls to validate and monitor the performance of their molecular diagnostic assays. Molecular diagnostic controls help assess the accuracy and precision of test results. By using controls with known concentrations of target biomolecules, laboratories can verify that their testing methods provide reliable and consistent results. Adherence to regulatory standards is crucial in the field of diagnostics. Molecular diagnostic controls are often required by regulatory agencies to ensure that laboratories meet quality and accuracy standards. Compliance with regulations helps maintain the integrity of diagnostic testing.
Data Bridge Market Research analyzes that the India molecular diagnostic controls market, which was USD 46.14 Million in 2023, is likely to reach USD 128.87 million by 2031 and is expected to undergo a CAGR of 13.7% during the forecast period. “Clinical laboratories” dominate the end user segment of the molecular diagnostic controls market due to the growing prevalence of infectious diseases.
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Report Metric
|
Details
|
|
Forecast Period
|
2024 to 2031
|
|
Base Year
|
2023
|
|
Historic Years
|
2022 (Customizable to 2016-2021)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product (Independent Controls, Instrument Specific Controls), Analyte Type (Single Analyte Controls, Multi Analyte Controls), Application (Infectious Disease, Oncology, Genetic Testing, Others), End User (Clinical Laboratories, Hospitals, IVD Manufacturers & Contract Research Organizations, Academic & Research Institutes, Others), Distribution Channel (Retail Sales, Direct Tender)
|
|
Country Covered
|
India
|
|
Market Players Covered
|
Thermo Fisher Scientific Inc. (U.S.), ASURAGEN, INC.(U.S.), Merck KGaA (Germany), SERACARE LIFE SCIENCES (U.S.), Bio-Rad Laboratories, Inc. (U.S.), bioMérieux SA (France), Abbott (U.S.), Microbiologics (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Molecular diagnostic controls are specific materials used in molecular diagnostic testing to ensure the accuracy, reliability, and precision of the results obtained from the testing process. Molecular diagnostics involves the analysis of genetic material, such as DNA or RNA, to detect and monitor various diseases, including genetic disorders, infectious diseases, and certain types of cancer.
Drivers
The rising prevalence of infectious diseases, genetic disorders, and chronic conditions is driving the demand for accurate and reliable diagnostic tests. Molecular diagnostic controls play a crucial role in ensuring the precision and reliability of these tests, contributing to effective disease management.
Ongoing advancements in molecular diagnostic technologies, including polymerase chain reaction (PCR), nucleic acid sequencing, and other molecular techniques, are expanding the capabilities of diagnostic testing. The development of new assays often requires corresponding molecular diagnostic controls for validation and quality assurance.
Opportunity
The growth of point-of-care testing, where diagnostic tests are conducted near the patient rather than in a centralized laboratory, is increasing the demand for reliable molecular diagnostic controls. These controls are crucial for maintaining the accuracy of tests performed outside traditional laboratory settings.
Restraint/Challenge
The regulatory approval processes for diagnostic controls can be lengthy and rigorous. Compliance with regulatory requirements is necessary for market entry, but it can pose a challenge in terms of time and resources. Delays in approvals may slow down the introduction of new molecular diagnostic controls to the market.
Recent Development
The molecular diagnostic controls market is segmented on the basis of product, analyte type, application, end-user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
Analyte Type
Application
End User
Distribution Channel
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The molecular diagnostic controls market also provides you with a detailed market analysis for every country's growth in healthcare expenditure for capital equipment, installed base of different kinds of products for the molecular diagnostic controls market, the impact of technology using lifeline curves and changes in healthcare regulatory scenarios and their impact on global the Molecular diagnostic controls market.
The molecular diagnostic controls market competitive landscape provides details by competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width, and breadth, application dominance. The above data points provided are only related to the companies' focus related to the molecular diagnostic controls market.
Some of the major players operating in the molecular diagnostic controls market are:
SKU-
TABLE 1 India molecular diagnostic controls Market, By product, 2019-2028 (USD MILLION)
TABLE 2 India Independent Controls in Molecular Diagnostic Controls Market, By Region, 2019-2028 (USD Million)
TABLE 3 India Instrument Specific Controls in Molecular Diagnostic Controls Market, By Region, 2019-2028 (USD Million)
TABLE 4 India Instrument Specific Controls in Molecular Diagnostic Controls Market, By Product, 2019-2028 (USD Million)
TABLE 5 India molecular diagnostic controls Market, By Analyte type, 2019-2028 (USD MILLION)
TABLE 6 India Single Analyte Controls in Molecular Diagnostic Controls Market, By Region, 2019-2028 (USD Million)
TABLE 7 India Multi Analyte Controls in Molecular Diagnostic Controls Market, By Region, 2019-2028 (USD Million)
TABLE 8 India molecular diagnostic controls Market, By application, 2019-2028 (USD MILLION)
TABLE 9 India Infectious Disease in Molecular Diagnostic Controls Market, By Region, 2019-2028 (USD Million)
TABLE 10 India Infectious Disease in Molecular Diagnostic Controls Market, By Application, 2019-2028 (USD Million)
TABLE 11 India Oncology in Molecular Diagnostic Controls Market, By Region, 2019-2028 (USD Million)
TABLE 12 India Genetic Testing in Molecular Diagnostic Controls Market, By Region, 2019-2028 (USD Million)
TABLE 13 India Others in Molecular Diagnostic Controls Market, By Region, 2019-2028 (USD Million)
TABLE 14 India molecular diagnostic controls Market, By end user, 2019-2028 (USD MILLION)
TABLE 15 India Clinical Laboratories in Molecular Diagnostic Controls Market, By Region, 2019-2028 (USD Million)
TABLE 16 India Hospitals in Molecular Diagnostic Controls Market, By Region r, 2019-2028 (USD Million)
TABLE 17 India IVD Manufacturers & Contract Research Organisations in Molecular Diagnostic Controls Market, By Region, 2019-2028 (USD Million)
TABLE 18 India Academic & Research Institutes in Molecular Diagnostic Controls Market, By Region, 2019-2028 (USD Million)
TABLE 19 India Others in Molecular Diagnostic Controls Market, By Region, 2019-2028 (USD Million)
TABLE 20 India molecular diagnostic controls Market, By distribution channel, 2019-2028 (USD MILLION)
TABLE 21 India Retail Sales in Molecular Diagnostic Controls Market, By Region, 2019-2028 (USD Million)
TABLE 22 India Direct Tenders in Molecular Diagnostic Controls Market, By Region, 2019-2028 (USD Million)
TABLE 23 INDIA MOLECULAR DIAGNOSTIC CONTROLS MARKET, by product, 2019-2028 (USD Million)
TABLE 24 India Instrument Specific Controls in Molecular Diagnostic Controls Market, By Product, 2019-2028 (USD Million)
TABLE 25 India Molecular Diagnostic Controls Market, By Analyte Type, 2019-2028 (USD Million)
TABLE 26 India Molecular Diagnostic Controls Market, By Application, 2019-2028 (USD Million)
TABLE 27 India Infectious Disease in Molecular Diagnostic Controls Market, By Application, 2019-2028 (USD Million)
TABLE 28 India Molecular Diagnostic Controls Market, By End User, 2019-2028 (USD Million)
TABLE 29 India Molecular Diagnostic Controls Market, By Distribution Channel, 2019-2028 (USD Million)
FIGURE 1 India molecular diagnostic controls MARKET: SEGMENTATION
FIGURE 2 INDIA MOLECULAR DIAGNOSTIC CONTROLS MARKET: DATA TRIANGULATION
FIGURE 3 India molecular diagnostic controls market: DROC ANALYSIS
FIGURE 4 India molecular diagnostic controls market: Global VS. REGIONAL MARKET ANALYSIS
FIGURE 5 India molecular diagnostic controls market: COMPANY RESEARCH ANALYSIS
FIGURE 6 India molecular diagnostic controls market: MULTIVARIATE MODELLING
FIGURE 7 India molecular diagnostic controls market: INTERVIEW DEMOGRAPHICS
FIGURE 8 INDIA MOLECULAR DIAGNOSTIC CONTROLS MARKET: DBMR MARKET POSITION GRID
FIGURE 9 INDIA MOLECULAR DIAGNOSTIC CONTROLS MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 India molecular diagnostic controls market: MARKET application COVERAGE GRID
FIGURE 11 India molecular diagnostic controls market: SEGMENTATION
FIGURE 12 Europe is expected to DOMINATE THE India molecular diagnostic controls market AND india IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 13 increasing prevalence of infectious diseases and cancer is expected to DRIVe THE India molecular diagnostic controls market IN THE FORECAST PERIOD OF 2021 to 2028
FIGURE 14 product SEGMENT is expected to account for the largest share of the India molecular diagnostic controls MARKET in 2021 & 2028
FIGURE 15 InDIA is the fastest growing market FOR the India Molecular diagnostic controls MANUFACTURERS IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 16 DRIVERS, RESTRAINT, OPPORTUNITIES, AND CHALLENGE OF India molecular diagnostics controls Market
FIGURE 17 India molecular diagnostic controls MARKET: BY product, 2020
FIGURE 18 India molecular diagnostic controls MARKET: BY product, 2021-2028 (USD MILLION)
FIGURE 19 India molecular diagnostic controls MARKET: BY product, CAGR (2021-2028)
FIGURE 20 India molecular diagnostic controls MARKET: BY product, LIFELINE CURVE
FIGURE 21 India molecular diagnostic controls MARKET: BY ANALYTE TYPE, 2020
FIGURE 22 India molecular diagnostic controls MARKET: BY ANALYTE TYPE, 2021-2028 (USD MILLION)
FIGURE 23 India molecular diagnostic controls MARKET: BY ANALYTE TYPE, CAGR (2021-2028)
FIGURE 24 India molecular diagnostic controls MARKET: BY ANALYTE TYPE, LIFELINE CURVE
FIGURE 25 India molecular diagnostic controls MARKET: BY application, 2020
FIGURE 26 India molecular diagnostic controls MARKET: BY application, 2021-2028 (USD MILLION)
FIGURE 27 India molecular diagnostic controls MARKET: BY application, CAGR (2021-2028)
FIGURE 28 India molecular diagnostic controls MARKET: BY application, LIFELINE CURVE
FIGURE 29 India molecular diagnostic controls MARKET: BY end user, 2020
FIGURE 30 India molecular diagnostic controls MARKET: BY end user, 2021-2028 (USD MILLION)
FIGURE 31 India molecular diagnostic controls MARKET: BY end user, CAGR (2021-2028)
FIGURE 32 India molecular diagnostic controls MARKET: BY end user, LIFELINE CURVE
FIGURE 33 India molecular diagnostic controls MARKET: BY distribution channel, 2020
FIGURE 34 India molecular diagnostic controls MARKET: BY distribution channel, 2021-2028 (USD MILLION)
FIGURE 35 India molecular diagnostic controls MARKET: BY distribution channel, CAGR (2021-2028)
FIGURE 36 India molecular diagnostic controls MARKET: BY distribution channel, LIFELINE CURVE
FIGURE 37 INDIA MOLECULAR DIAGNOSTIC CONTROLS MARKET: company share 2020 (%)
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.